ImproVue (Oculus Surgical, Inc.)


Welcome to the PulseAid listing for the ImproVue drug offered from Oculus Surgical, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Oculus Surgical, Inc.
NON-PROPRIETARY NAME: HYPROMELLOSE 2208 (15000 MPA.S)
SUBSTANCE NAME: HYPROMELLOSE 2208 (15000 MPA.S)
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION/ DROPS
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2014-06-25
END MARKETING DATE: 0000-00-00


ImproVue HUMAN OTC DRUG Details:

Item DescriptionImproVue from Oculus Surgical, Inc.
LABELER NAME: Oculus Surgical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 17(mg/mL)
START MARKETING DATE: 2014-06-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62144-5510_2b072821-c4b6-4267-a6b1-844536e0b7e8
PRODUCT NDC: 62144-5510
APPLICATION NUMBER: part349

Other HYPROMELLOSE 2208 (15000 MPA.S) Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
OASIS Medical, Inc.VISCO SHIELD
Oculus Surgical, Inc.ImproVue